MRPL52 maintains hypoxic BC cell viability by promoting PINK1/Parkin-dependent mitophagy and mediates hypoxic-induced metastatic initiation of BC cells by transactivating the ROS-Notch1-Snail pathway. Here, MRPL52 is linked to breast cancer.